No abstract available
MeSH terms
-
Antineoplastic Agents, Immunological / therapeutic use*
-
Carcinoma, Hepatocellular / mortality
-
Carcinoma, Hepatocellular / pathology
-
Carcinoma, Hepatocellular / radiotherapy*
-
Female
-
Humans
-
Kaplan-Meier Estimate
-
Liver Neoplasms / mortality
-
Liver Neoplasms / pathology
-
Liver Neoplasms / radiotherapy*
-
Male
-
Nivolumab / therapeutic use*
-
Programmed Cell Death 1 Receptor / antagonists & inhibitors
-
Radioimmunotherapy / methods*
-
Salvage Therapy / methods
-
Treatment Outcome
Substances
-
Antineoplastic Agents, Immunological
-
Programmed Cell Death 1 Receptor
-
Nivolumab